BCAL Diagnostics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Shane Ryan
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 2.5yrs |
Recent management updates
Recent updates
CEO
Shane Ryan
less than a year
Tenure
Mr. Shane Ryan, MBA is Chief Executive Officer of BCAL Diagnostics Limited from 2024. He joined the BCAL Diagnostics Limited on September 21, 2023. He was Chief Operating Officer of BCAL Diagnostics Limite...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman | 14.3yrs | AU$180.00k | 12.01% A$ 2.9m | |
Co-Founder & Non-Executive Director | 14.3yrs | AU$52.31k | 10.86% A$ 2.7m | |
Independent Non-Executive Director | less than a year | AU$530.95k | 2.18% A$ 534.7k | |
Independent Non-Executive Director | 2.8yrs | AU$52.31k | 0.55% A$ 135.8k | |
Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | 3.4yrs | AU$52.31k | 1.9% A$ 465.9k | |
Scientific Advisory Board Member | no data | no data | no data | |
Scientific Advisory Board Member | no data | no data | no data | |
Scientific Advisory Board Member | no data | no data | no data | |
Scientific Advisory Board Member | 2.2yrs | no data | no data | |
Scientific Advisory Board Member | 2.2yrs | no data | no data |
2.5yrs
Average Tenure
Experienced Board: BDX's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.